BOOK
Dermatologic Manifestations of the Lower Extremity, An Issue of Clinics in Podiatric Medicine and Surgery, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Clinics in Podiatric Medicine and Surgery will focus on the dermatologic manifestations of the lower extremity. Articles will include: Fungal, Nail Surgery, Psoriasis, Eczema, Drug Reactions, Melanoma, and many more.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Dermatological Manifestations of the Lower Extremity\r | i | ||
Copyright\r | ii | ||
Clinics in Podiatric Medicine and Surgery | iii | ||
Consulting Editor | iii | ||
Editorial Board Members - USA | iii | ||
Editorial Board Members - International | iii | ||
Contributors | v | ||
CONSULTING EDITOR | v | ||
EDITOR | v | ||
AUTHORS | v | ||
Contents | vii | ||
Foreword: Lower Extremity Skin Manifestations\r | vii | ||
Preface: Lower Extremity Skin Manifestations: A Multidisciplinary Effort\r | vii | ||
Onychomycosis: Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes\r | vii | ||
Dermatologic Manifestations of the Lower Extremity: Nail Surgery\r | vii | ||
The Human Papillomavirus and Its Role in Plantar Warts: A Comprehensive Review of Diagnosis and Management\r | vii | ||
Psoriasis: Pathogenesis, Assessment, and Therapeutic Update\r | viii | ||
Dermatologic Concerns of the Lower Extremity in the Pediatric Patient\r | viii | ||
Importance of Vehicles in Topical Treatment of Fungal Infections\r | viii | ||
Adverse Drug Reactions of the Lower Extremities\r | viii | ||
Melanoma of the Foot\r | ix | ||
Cutaneous Markers of Systemic Disease in the Lower Extremity\r | ix | ||
Plantar Hyperhidrosis: An Overview\r | ix | ||
CLINICS IN PODIATRIC\rMEDICINE AND SURGERY\r | x | ||
FORTHCOMING ISSUES | x | ||
October 2016 | x | ||
January 2017 | x | ||
April 2017 | x | ||
July 2017 | x | ||
October 2017 | x | ||
RECENT ISSUES | x | ||
April 2016 | x | ||
January 2016 | x | ||
October 2015 | x | ||
July 2015 | x | ||
Forword: Lower Extremity Skin Manifestations\r | xi | ||
Preface: Lower Extremity Skin Manifestations: A Multidisciplinary Effort\r | xiii | ||
Onychomycosis | 305 | ||
Key points | 305 | ||
INTRODUCTION | 305 | ||
PATIENT EVALUATION | 306 | ||
PHARMACOLOGIC TREATMENT OPTIONS: FOCUS ON TOPICAL THERAPY | 307 | ||
NONPHARMACOLOGIC TREATMENTS | 310 | ||
COMBINATION THERAPY | 310 | ||
SURGICAL TREATMENT OPTIONS | 311 | ||
MANAGEMENT OF RECURRENCE | 311 | ||
EVALUATING PATIENT OUTCOMES AND LONG-TERM MANAGEMENT | 313 | ||
SUMMARY | 314 | ||
REFERENCES | 314 | ||
Dermatologic Manifestations of the Lower Extremity | 319 | ||
Key points | 319 | ||
INTRODUCTION: PATIENT EVALUATION OVERVIEW | 319 | ||
PATHOLOGIC CONDITIONS REQUIRING NAIL SURGERY (BENIGN AND MALIGNANT TUMORS, INFLAMMATORY DERMATOSES, CONGENITAL DISORDERS) | 320 | ||
SURGICAL APPROACH AND TECHNIQUES | 323 | ||
Scrub | 323 | ||
Anesthesia | 325 | ||
Bloodless Field | 325 | ||
Punch | 326 | ||
Shave | 329 | ||
Biopsy of Longitudinal Erythronychia | 330 | ||
Lateral Longitudinal Excision | 331 | ||
En Bloc | 331 | ||
COMPLICATIONS | 333 | ||
SUMMARY | 333 | ||
REFERENCES | 333 | ||
The Human Papillomavirus and Its Role in Plantar Warts | 337 | ||
Key points | 337 | ||
INTRODUCTION | 337 | ||
Human Papilloma Virus in Depth | 338 | ||
Human Papilloma Virus Structure | 339 | ||
PATIENT EVALUATION OVERVIEW | 340 | ||
Clinical Manifestations of Human Papilloma Virus Infection | 340 | ||
Evaluation of Patients with Plantar Warts | 344 | ||
CLINICAL MANAGEMENT OF VERRUCA PEDIS | 345 | ||
Pharmacologic and Nonpharmacologic Treatment Options | 345 | ||
Folk remedies | 345 | ||
Salicylic acid | 346 | ||
Cryotherapy | 346 | ||
Topical retinoids | 346 | ||
Topical 5-fluorouracil | 346 | ||
Cimetidine | 347 | ||
Duct tape | 347 | ||
Cantharidin | 347 | ||
Bleomycin | 347 | ||
Candida immunotherapy | 348 | ||
Phytotherapy | 348 | ||
Human papilloma virus vaccine | 349 | ||
LASER | 349 | ||
SURGICAL TREATMENT OPTIONS | 350 | ||
SUMMARY/DISCUSSION | 350 | ||
REFERENCES | 350 | ||
Psoriasis | 355 | ||
Key points | 355 | ||
PATHOGENESIS | 356 | ||
GENETICS | 356 | ||
CLINICAL PRESENTATIONS OF PSORIASIS | 356 | ||
NONDERMATOLOGIC MANIFESTATIONS | 357 | ||
ARTHRITIS | 359 | ||
COMORBIDITIES | 361 | ||
TREATMENT | 362 | ||
Topical Therapies | 362 | ||
Phototherapy | 363 | ||
Oral systemic therapies | 363 | ||
Biologics | 363 | ||
Adalimumab | 363 | ||
Etanercept | 364 | ||
Infliximab | 364 | ||
Ustekinumab | 364 | ||
Secukinumab | 364 | ||
REFERENCES | 365 | ||
Dermatologic Concerns of the Lower Extremity in the Pediatric Patient | 367 | ||
Key points | 367 | ||
DIAGNOSING SKIN DISEASE IN THE PEDIATRIC POPULATION | 367 | ||
Observe | 367 | ||
Ask | 368 | ||
A Note on Skin Biopsies and Other Cutaneous Procedures in the Pediatric Patient | 368 | ||
ENVIRONMENTALLY INDUCED SKIN DISORDERS | 369 | ||
Sun Exposure | 369 | ||
Heat and Cold | 369 | ||
Bites and Stings and Infestations | 370 | ||
Trauma | 370 | ||
GENODERMATOSES | 371 | ||
Vörner-Unna-Thost Type | 371 | ||
Vohwinkel Type | 371 | ||
Pachyonychia Congenita | 371 | ||
Tuberous Sclerosis | 371 | ||
Treatment of Genodermatoses | 372 | ||
BACTERIAL INFECTIONS | 372 | ||
Impetigo | 372 | ||
Cellulitis | 372 | ||
Folliculitis | 372 | ||
Pitted Keratolysis/Erythrasma | 373 | ||
Pseudomonas Hot Foot Syndrome | 373 | ||
VIRAL INFECTIONS | 373 | ||
Viral Exanthems | 373 | ||
Measles | 373 | ||
Rubella | 373 | ||
Fifth disease or erythema infectiosum | 373 | ||
Varicella Zoster | 373 | ||
Herpes simplex | 374 | ||
Hand-foot-and-mouth disease | 374 | ||
Molluscum Contagiosum | 374 | ||
Verrucae | 374 | ||
FUNGAL INFECTIONS | 375 | ||
Tinea Capitis | 375 | ||
Tinea Pedis | 375 | ||
Tinea Incognito | 375 | ||
Onychomycosis | 376 | ||
Distal (or distal lateral) subungual | 376 | ||
Proximal subungual | 376 | ||
Candidal | 376 | ||
Superficial white | 376 | ||
Candidiasis | 376 | ||
ECZEMA/DERMATITIS | 377 | ||
Overview | 377 | ||
Endogenous Eczema | 377 | ||
Atopic dermatitis | 377 | ||
Juvenile plantar dermatosis (sweaty sock dermatitis) | 377 | ||
Pompholyx (dyshidrotic eczema) | 378 | ||
Exogenous Eczema/Dermatitis | 378 | ||
Allergic contact dermatitis | 378 | ||
Irritant contact dermatitis | 378 | ||
Focus on Eczema/Dermatitis of the Lower Extremity | 379 | ||
General Management of Eczema | 379 | ||
PSORIASIS | 379 | ||
Plaque Psoriasis | 379 | ||
Pustular Psoriasis | 380 | ||
Guttate Psoriasis | 380 | ||
Focus on Psoriasis of the Lower Extremity | 380 | ||
General Management of Psoriasis | 380 | ||
NEVI | 381 | ||
NAILS | 382 | ||
REFERENCES | 382 | ||
Importance of Vehicles in Topical Treatment of Fungal Infections | 385 | ||
Key points | 385 | ||
TOPICAL DRUG DELIVERY BASICS | 386 | ||
Secondary Formulations | 388 | ||
THE DOSAGE FORM | 388 | ||
TREATMENT SELECTION | 390 | ||
Anticipated Efficacy | 390 | ||
Supportive Effects | 391 | ||
Practical Considerations | 391 | ||
SUMMARY | 392 | ||
REFERENCES | 393 | ||
Adverse Drug Reactions of the Lower Extremities | 397 | ||
Key points | 397 | ||
ADVERSE DRUG REACTIONS TO TOPICAL MEDICATIONS | 398 | ||
ADVERSE DRUG REACTIONS TO SYSTEMIC AGENTS | 399 | ||
FIXED DRUG ERUPTIONS | 399 | ||
MEDICATION-INDUCED LOWER LEG EDEMA | 400 | ||
ERYTHEMA NODOSUM CAUSED BY MEDICATIONS | 400 | ||
MEDICATION-INDUCED PIGMENTATION OF THE SKIN | 400 | ||
MEDICATION-INDUCED PIGMENTATION OF THE NAILS | 402 | ||
SKIN NECROSIS CAUSED BY ANTICOAGULANTS | 402 | ||
ADVERSE DRUG REACTIONS TO CHEMOTHERAPEUTIC AGENTS | 403 | ||
CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA | 403 | ||
CHEMOTHERAPY-INDUCED DERMATOLOGIC CHANGES INVOLVING THE LOWER EXTREMITY CAUSED BY VARIOUS CHEMOTHERAPY AGENTS | 403 | ||
CHEMOTHERAPY-INDUCED NAIL CHANGES | 404 | ||
ADVERSE REACTIONS TO IMMUNOSUPPRESSIVE OR IMMUNOMODULATORY AGENTS | 405 | ||
OTHER NAIL CHANGES CAUSED BY MEDICATIONS | 405 | ||
REFERENCES | 406 | ||
Melanoma of the Foot | 409 | ||
Key points | 409 | ||
INTRODUCTION | 409 | ||
TYPES OF MELANOMA | 409 | ||
AMELANOTIC MELANOMA | 410 | ||
NAIL MELANOMA | 410 | ||
HOW COMMON IS MELANOMA ON THE FOOT? | 411 | ||
CAUSE | 412 | ||
CLINICAL PRESENTATION OF MELANOMA ON THE FOOT | 413 | ||
PRESENTATION OF MELANOMA OF THE NAIL UNIT | 414 | ||
DERMOSCOPY | 417 | ||
DIAGNOSIS AND STAGING OF MELANOMA | 417 | ||
PROGNOSIS | 418 | ||
CURRENT AND RECENT ADVANCES IN THE TREATMENT OF MELANOMA | 419 | ||
REFERENCES | 420 | ||
Cutaneous Markers of Systemic Disease in the Lower Extremity | 423 | ||
Key points | 423 | ||
INTRODUCTION | 423 | ||
DIABETES MELLITUS | 423 | ||
Diabetic Dermopathy | 423 | ||
Bullosis Diabeticorum | 424 | ||
Diabetic Eruptive Xanthomas | 425 | ||
Necrobiosis Lipoidica Diabeticorum | 425 | ||
RENAL DISEASE | 426 | ||
Acquired Perforating Dermatosis of End-stage Renal Disease (Kyrle Disease) | 426 | ||
Nephrogenic Fibrosing Dermopathy | 426 | ||
Calciphylaxis | 427 | ||
CARDIOVASCULAR DISORDERS | 428 | ||
Raynaud Phenomenon | 428 | ||
Subacute Bacterial Endocarditis | 428 | ||
Henoch-Schönlein Purpura | 428 | ||
THYROID CONDITIONS | 429 | ||
Thyroid Dermopathy (Pretibial Myxedema) | 429 | ||
MALIGNANCY | 429 | ||
Bazex Syndrome | 430 | ||
Glucagonoma Syndrome | 430 | ||
Malignant Acanthosis Nigricans | 430 | ||
Ichthyosis | 430 | ||
Palmoplantar Keratoderma | 430 | ||
Trousseau Syndrome | 431 | ||
Werner Syndrome | 431 | ||
GENETIC DISORDERS | 431 | ||
Neurofibromatosis | 431 | ||
Tuberous Sclerosis | 431 | ||
THE ERYTHEMAS | 432 | ||
Erythema Multiforme | 432 | ||
Erythema Nodosum | 432 | ||
Erythema Annulare Centrifugum | 433 | ||
Palmoplantar Erythema | 434 | ||
MISCELLANEOUS DISORDERS | 434 | ||
Keratoderma Blennorrhagicum | 434 | ||
Pyoderma Gangrenosum | 435 | ||
Vitiligo | 436 | ||
NAIL MANIFESTATIONS OF INTERNAL DISEASE | 437 | ||
Beau Lines | 437 | ||
Yellow Nail Syndrome | 437 | ||
Koilonychia | 437 | ||
Digital Clubbing | 437 | ||
Terry Nails | 438 | ||
SUMMARY | 439 | ||
REFERENCES | 439 | ||
Plantar Hyperhidrosis | 441 | ||
Key points | 441 | ||
INTRODUCTION | 441 | ||
PATIENT EVALUATION OVERVIEW | 442 | ||
PHARMACOLOGIC TREATMENT OPTIONS | 445 | ||
NONPHARMACOLOGIC TREATMENT OPTIONS | 448 | ||
SUMMARY/DISCUSSION | 449 | ||
ACKNOWLEDGMENT | 449 | ||
REFERENCES | 450 | ||
Index | 453 |